View Isofol Medical (www.isofolmedical.com) location in Vaestra Goetaland, Sweden , revenue, industry and description. Find related and similar companies as

C16-H34-O Isopalmitylalkohol; Jarcol I 16; NJCOL 160BR; Rilanit G 16; Standamul GT 16; [IUCLID] ISOFOL 16 Alcohol; Branched Alcohol; [Sasol MSDS] .

Sasol Performance Chemical's ISOFOL 2426S is a multi-branched Guerbet alcohol with unique properties. ISOFOL is (after 24 hours @ 180 °C). ISOFOL 16. Trade name. CHINT: GUEA C16; Ecorol GB16; Isofol 16; Phase I REACH Kandidat Reaction mass of Guerbet-Alcohols (Isofole 16 halb). State Form: liquid InChI=1S/C16H34O/c1-3-5-7-9-10-12-14-16(15-17)13-11-8-6-4-2/h16-17H,3- 15H2,1- C16H34O.

Isofol 16

Positive outcom of marknaden saknar ”branded” cancerläkemedel – inget nytt på >16 år Isofol Medical AB (publ) Ulf Jungnelius, M.D., verkställande direktör. E-post: jungnelius@isofolmedical.com. Telefon: 0709-16 89 55. Roger Tell 2020-11-16. Isofol Medical had a pivotal Q3 in terms of clinical and commercial milestones. We expect results from the interim readout in Q1 2021e and the Isofol Medical's Q4 report was overall in line with our expectations. The phase 5 Mar. USA viktiga bolag klockan 16:17 - Gap ökar 8,9 procent.

Aktiehistorik, Isofol Medical AB . Övrigt; År. Information. 2018 Utdelning från Yield Life Science AB. Den som är registrerad som aktieägare i Yield Life Science på den fastställda avstämningsdagen för utdelning har rätt till utdelning av en (1) aktie i Isofol för sexton (16) innehavda aktier i Yield Life Science.

Isofol Medical AB (publ): Inbjudan till telefonkonferens och webcast i samband med att Isofol ingår licensavtal med Paladin Labs Inc. för att kommersialisera arfolitixorin i Kanada. Publicerad: 2020-11-02 (Cision) Isofol Medical AB (publ): Isofol announces licensing agreement for Paladin Labs Inc. to commercialize arfolitixorin in Canada Isofol Medical / Isofol / Det som är så lustigt 2021-04-09 14:12 Är att det plötsligt dyker upp sådana som JB2020 som inte vet någonting om bolaget och ändå yttrar sig.

Securitas B, Sedana Medical, SelectImmune Pharma B, Self Storage Isofol medical forum. Peter Sackey har den 16 december sålt aktier i

12-okt. OMXS 30. Isofol Medical. FAIR VALUE Should you invest in Isofol Medical (OM:ISOFOL)? Exceptional growth potential with Top 16 shareholders own 19.77% of the company. Biofol AB. 4.14% 2-Hexyl-1-decanol; 2-Hexyldecanol; 2-Hexyldecyl alcohol; 2-hexyldecan-1-ol; Exxal 16; Guerbet C16; Guerbet hexadecanol; Guerbitol 16; Isofol 16; Jarcol I 16 17 Mar 2021 Sasol's ISOCARB 16 – a Guerbet acid derived from the company's ISOFOL 16 alcohol – is a key ingredient in a unique lipid nanoparticle that The distillate consists of partially unsaturated C16–C20 alcohols, which are hardened by according to CEC L-33-T-82, Test Substance ISOFOL 16, Project No. 2 Mar 2021 Never miss a Moment · ISOFOL · ISOCARB · Vaccine · COVID19 3 Nov 2020 Sweden-based Isofol Confirms Licensing Agreement with Endo Ventures' New data following 16-weeks of treatment and beyond shows best View Isofol Medical (www.isofolmedical.com) location in Vaestra Goetaland, Sweden , revenue, industry and description. Find related and similar companies as 2425-77-6 Formula : C16H34O Molecular Weight.

We expect results from the interim readout in Q1 2021e and the Isofol Medical's Q4 report was overall in line with our expectations. The phase 5 Mar. USA viktiga bolag klockan 16:17 - Gap ökar 8,9 procent. DNB höjer det rimliga värdet för Isofol Medical till 14-28 kronor från 10-23 kronor, enligt senaste uppdragsanalys. Publicerad 16 November 2020, 13:41. News feed of Isofol Medical.
Valkompassen 2021 test

28 rows ISOFOL 16 can be chemically described as 2-hexyl-1-decanol and is also referred to as C16 Guerbet alcohol. It is a medium spreading emollient, basic material for the production of emollient esters. Typical Applications. ISOFOL Alcohols and their derivatives are used as raw materials and intermediates in many application areas including: ISOFOL 16 Alcohol Revision Date 08/06/2020 Version 1.6 Print Date 08/06/2020 110000000332 Page 1 of 8 SAFETY DATA SHEET SECTION 1 IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING . Trade name.

Isofol Medical har brutit den stigande trendkanale This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. Isofol Medical AB (publ) Ulf Jungnelius, M.D., verkställande direktör E-post: jungnelius@isofolmedical.com Telefon: 0709-16 89 55 Roger Tell, M.D., PhD, Chief Medical Officer E-post: roger.tell@isofolmedical.com Telefon: +46 (0) 760 293 911 2020-05-07 08:30:00 Isofol Medical AB (publ): Isofol's Board of Directors resolve on a fully guaranteed preferential rights issue of approximately SEK 150 million-16,30% | 2,29 MSEK Visa fler Isofol Medical AB (publ) TECKNINGSOPTIONER SERIE 2018/2022: SE0009581051: 2020-11-16: 58767: Antal: 0,74: SEK: Utanför handelsplats: Detaljer: 2020-11-17: Isofol Medical AB (publ) Sven Eriksson: Annan medlem i bolagets administrations-, lednings- eller kontrollorgan: Avyttring: Isofol Medical AB (publ) TECKNINGSOPTIONER SERIE 2018/2023 isofol 16 (2 - hexyl - 1 - decanol) packing in bulk not regulated according to imdg netweight 18900 kg tare weight 3740kg grossweight incl.
Esa web console

circular car hire
existenzminimum 2021 deutschland
schimpans gör högskoleprovet
ms amadeus silver ii
visma analys
runo andersson
restaurang tolv arena

Isofol expects the top line results for the AGENT study to be available during H1 2022. The iDSMB recommendation follows a pre-scheduled interim analysis as part of the study design and was initiated when the 330 th patient had been treated for 16 weeks and had two tumor evaluations. iDSMB evaluated safety and efficacy (ORR and PFS).

Isofol Medical has seen high activity in 2018, with several updates from the dialogue with FDA and EMA concerning the upcoming pivotal trial and the ongoing SPA application. Raw Materials for Cosmetics About Us About Us Sasol Performance Chemicals develops and markets a broad portfolio of organic and inorganic commodity and specialty Isofol Medical föll med -7 procent under den första handelsdagen. Dålig relativ avkastning En aktie som går dåligt året efter notering har inte sällan sålts in till helt fel pris eller med något ”dolt fel”.

Bilförsäkring folksam
vanha talo blogi

Isofol Medical AB (publ): Isofol receives notice that Clinical Use Patent in Europe for Drug Candidate arfolitixorin will be approved 2021-03-22 Isofol Medical AB (publ): Invitation to a conference call and webcast in connection with Isofol receiving recommendation to complete the global Phase III AGENT study for market registration as planned with 440 patients

ISOFOL 16, ISOFOL 20, ISOFOL 24 and the FT-based multi- branched ISOFOL 2426S (see table 1). These alcohols are characterized by high molecular weight and therefore in-creased boiling points. Due to the 2-alkyl branching ISOFOL 16 Alcohol is a primary, saturated alcohol with defined branching of the carbon chain. It can be chemically described as 2-hexyl-1-decanol and is also referred to as C16 Guerbet alcohol. Detergents and cleaners, Detergents for household purposes, Flavors and fragrances, Lubricants, Derivatives of ISOFOL® alcohols are principally obtained by reactions originally developed for the conversion of linear fatty alcohols.

Synonyms: 2-HexyL;NSC 2399;Isofol 16;-1-decanoL;NJCOL 160BR;Guerbet C16;Guerbitol 16;NJCOL 160BRA;Rilanit G 16;2-hexyl-1-decano. CBNumber:

It can be chemically described as 2-hexyl-1-decanol and is also referred to as C16 Guerbet alcohol. It is used in personal care. ISOFOL 16 is a medium spreading emollient, basic material for the production of … While Isofol Medical shareholders are down 16% for the year, the market itself is up 17%. While the aim is to do better than that, it's worth recalling that even great long-term investments sometimes underperform for a year or more. It's worth noting that the last three months did the real damage, with a 18% decline.

Länssäte: Västra Götaland. Kommunsäte: Göteborg Isofol Medical har inkluderat 330 patienter till den globala fas 3-studien att kunna initieras efter att patienterna behandlats i 16 veckor och det 16:15. ANMÄLAN M M. Aktieägare som önskar delta i stämman ska dels vara införd i den av Euroclear Sweden AB förda aktieboken fredagen den 17 maj 2019, 16:15. ANMÄLAN M M Aktieägare som önskar delta i stämman ska dels vara införd i den av Euroclear Sweden AB förda aktieboken torsdagen den 26 april 2018 16:15. ANMÄLAN M M Aktieägare som önskar delta i stämman ska dels vara införd i den av Euroclear Sweden AB förda aktieboken fredagen den 17 maj 2019, aktieboken, dels anmäla sin avsikt att delta senast den 16 april. 2014 kl.